Viewing Study NCT03780361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2026-02-20 @ 7:25 PM
Study NCT ID: NCT03780361
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2018-12-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)
Sponsor: Hyewon Chung
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None soluble CD14 View
None MCP-1 View
None IL-6 View
None ICAM-1 View
None cytokine View
None visual acuity View
None optical coherence tomography View
None macular thickness View
None hyperreflective foci View